JP2013515009A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013515009A5 JP2013515009A5 JP2012544948A JP2012544948A JP2013515009A5 JP 2013515009 A5 JP2013515009 A5 JP 2013515009A5 JP 2012544948 A JP2012544948 A JP 2012544948A JP 2012544948 A JP2012544948 A JP 2012544948A JP 2013515009 A5 JP2013515009 A5 JP 2013515009A5
- Authority
- JP
- Japan
- Prior art keywords
- hmb
- composition
- muscle
- acid
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AXFYFNCPONWUHW-UHFFFAOYSA-N 3-hydroxyisovaleric acid Chemical compound CC(C)(O)CC(O)=O AXFYFNCPONWUHW-UHFFFAOYSA-N 0.000 claims 75
- 239000002253 acid Substances 0.000 claims 10
- 210000003205 muscle Anatomy 0.000 claims 9
- 230000000694 effects Effects 0.000 claims 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 6
- 208000029549 Muscle injury Diseases 0.000 claims 6
- 159000000007 calcium salts Chemical class 0.000 claims 5
- 230000036470 plasma concentration Effects 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 230000028993 immune response Effects 0.000 claims 3
- 150000002632 lipids Chemical class 0.000 claims 3
- 230000014759 maintenance of location Effects 0.000 claims 3
- 230000004220 muscle function Effects 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 210000001519 tissue Anatomy 0.000 claims 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 230000037396 body weight Effects 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 230000002503 metabolic effect Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28785709P | 2009-12-18 | 2009-12-18 | |
| US61/287,857 | 2009-12-18 | ||
| PCT/US2010/061367 WO2011075741A1 (en) | 2009-12-18 | 2010-12-20 | Improved method of administering beta-hydroxy-beta-methylbutyrate (hmb) |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015188107A Division JP2016026181A (ja) | 2009-12-18 | 2015-09-25 | β−ヒドロキシ−β−メチル酪酸塩（ＨＭＢ）の改善された投与方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013515009A JP2013515009A (ja) | 2013-05-02 |
| JP2013515009A5 true JP2013515009A5 (enExample) | 2013-09-26 |
| JP6077857B2 JP6077857B2 (ja) | 2017-02-08 |
Family
ID=44167737
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012544948A Active JP6077857B2 (ja) | 2009-12-18 | 2010-12-20 | β−ヒドロキシ−β−メチル酪酸塩（ＨＭＢ）の改善された投与方法 |
| JP2015188107A Pending JP2016026181A (ja) | 2009-12-18 | 2015-09-25 | β−ヒドロキシ−β−メチル酪酸塩（ＨＭＢ）の改善された投与方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015188107A Pending JP2016026181A (ja) | 2009-12-18 | 2015-09-25 | β−ヒドロキシ−β−メチル酪酸塩（ＨＭＢ）の改善された投与方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20120053240A1 (enExample) |
| EP (1) | EP2512236B1 (enExample) |
| JP (2) | JP6077857B2 (enExample) |
| CN (1) | CN102762097B (enExample) |
| CA (1) | CA2784836C (enExample) |
| DK (1) | DK2512236T3 (enExample) |
| ES (1) | ES2608483T3 (enExample) |
| HU (1) | HUE032486T2 (enExample) |
| PL (1) | PL2512236T3 (enExample) |
| PT (1) | PT2512236T (enExample) |
| WO (1) | WO2011075741A1 (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2631597C2 (ru) * | 2011-07-15 | 2017-09-25 | Нусерт Сайенсиз, Инк. | Композиции и способы модулирования метаболических путей |
| EP3733171B1 (en) | 2012-09-10 | 2023-10-25 | Metabolic Technologies, LLC | Compositions comprising hmb and atp as well as their use |
| EP2993994A4 (en) * | 2013-03-14 | 2016-11-23 | Metabolic Technologies Inc | LIQUIDS AND FOODS WITH BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) IN A FREE ACID FORM |
| CA2904119C (en) | 2013-03-14 | 2018-01-02 | Abbott Laboratories | Treatment of insulin resistance associated with prolonged physical inactivity |
| US20140272000A1 (en) * | 2013-03-14 | 2014-09-18 | Metabolic Technologies, Inc. | Liquids and Foodstuffs Containing beta-hydroxy-beta-methylbutyrate (HMB) in the Free Acid Form and Methods of Manufacturing or Producing the Same |
| US20160037815A1 (en) * | 2013-03-15 | 2016-02-11 | Abbott Laboratories | Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, casein phosphopeptide, and protein |
| US20150057350A1 (en) * | 2013-08-23 | 2015-02-26 | Abbott Laboratories | Fibrosis biomarkers and methods of using same |
| EP3082778B1 (en) | 2013-12-18 | 2019-04-03 | Capsugel Belgium NV | Stable liquid filled hard capsule comprising beta-hydroxy-beta-methylbutyric acid |
| WO2015105981A2 (en) * | 2014-01-09 | 2015-07-16 | Abbott Laboratories | Conditional essentiality of hmb |
| CN106536060A (zh) | 2014-01-28 | 2017-03-22 | 卫理公会医院 | 包括单细胞移液器手柄和单细胞移液器尖端的单细胞移液器组件 |
| JP6309287B2 (ja) * | 2014-01-29 | 2018-04-11 | 協和発酵バイオ株式会社 | ３−ヒドロキシ−３−メチル酪酸カルシウム含有飲料 |
| HK1223509A1 (zh) * | 2014-03-14 | 2017-08-04 | 代谢科技有限公司 | 含有游离酸形式的β-羟基-β-甲基丁酸盐(HMB)的液体和食品 |
| US20160184248A1 (en) * | 2014-12-15 | 2016-06-30 | University Of Central Florida Research Foundation Inc. | Compositions and methods of use of -hydroxy-methylbutyrate (hmb) resulting in an acute endocrine response |
| HK1252405A1 (zh) * | 2015-06-01 | 2019-05-24 | 代谢科技有限公司 | 用於减少脂肪量的β-羟基-β-甲基丁酸(HMB)的组合物和使用方法 |
| FI3349745T3 (fi) * | 2015-09-16 | 2024-03-14 | Metabolic Tech Llc | Beeta-hydroksi-beeta-metyylibutyraatin (HMB) koostumukset ja käyttömenetelmät pehmytkudostraumasta toipumisen tehostamiseksi |
| US12208073B2 (en) | 2015-09-16 | 2025-01-28 | Metabolic Technologies, LLC | Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) for enhancing recovery from soft tissue trauma |
| EP3373740B9 (en) | 2015-11-10 | 2021-07-21 | Metabolic Technologies, Inc. | Compositions and methods of use of -hydroxy- -methylbutyrate (hmb) as an animal feed additive |
| CN108697675A (zh) * | 2016-01-13 | 2018-10-23 | 代谢科技有限公司 | 用于关节稳定性的β-羟基-β-甲基丁酸(HMB)的组合物和使用方法 |
| CN109641135A (zh) | 2016-01-21 | 2019-04-16 | 代谢科技有限公司 | β-羟基-β-甲基丁酸(HMB)用于调节自噬和噬脂的组合物和方法 |
| US11241403B2 (en) | 2016-03-11 | 2022-02-08 | Axcess Global Sciences, Llc | Beta-hydroxybutyrate mixed salt compositions and methods of use |
| US11103470B2 (en) | 2017-11-22 | 2021-08-31 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| US10925843B2 (en) | 2018-04-18 | 2021-02-23 | Axcess Global Sciences, Llc | Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate |
| US12329734B2 (en) | 2017-12-19 | 2025-06-17 | Axcess Global Sciences, Llc | Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow |
| US12496283B2 (en) | 2016-04-19 | 2025-12-16 | Axcess Global Sciences, Llc | Administration of R-beta-hydroxybutyrate and related compounds in humans |
| US12109182B2 (en) | 2016-04-19 | 2024-10-08 | Axcess Global Sciences, Llc | Administration of R-beta-hydroxybutyrate and related compounds in humans |
| US11202769B2 (en) | 2017-11-22 | 2021-12-21 | Axcess Global Sciences, Llc | Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function |
| US11806324B2 (en) | 2018-04-18 | 2023-11-07 | Axcess Global Sciences, Llc | Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies |
| US11944598B2 (en) | 2017-12-19 | 2024-04-02 | Axcess Global Sciences, Llc | Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer |
| MX2018014407A (es) * | 2016-05-25 | 2019-02-21 | Tsi Group Ltd | Estabilizacion de formulaciones de acido beta-hidroxiisovalerico en capsulas de gel blando. |
| US10588877B2 (en) | 2016-07-21 | 2020-03-17 | Savind, Inc. | Compositions comprising β-hydroxybutyric acid and salt, and methods of using the same |
| FI3528801T3 (fi) | 2016-10-21 | 2024-10-24 | Metabolic Tech Llc | Beeta-hydroksi-beeta-metyylibutyraatin (hmb) ja probioottien koostumuksia ja menetelmiä niiden käyttämiseksi |
| US12370159B2 (en) * | 2016-10-21 | 2025-07-29 | Metabolic Technologies, LLC | Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) and probiotics |
| JP7022420B2 (ja) * | 2017-06-30 | 2022-02-18 | 株式会社東洋新薬 | 経口組成物 |
| US12090129B2 (en) | 2017-11-22 | 2024-09-17 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| MY209267A (en) * | 2018-01-05 | 2025-06-30 | Texas Tech Univ Office Of Research Commercialization | Compositions and methods of use of -hydroxy--methylbutyrate (hmb) assosiated with intermittent fasting |
| US11419836B2 (en) | 2019-02-13 | 2022-08-23 | Axcess Global Sciences, Llc | Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions |
| US10888576B2 (en) | 2018-10-08 | 2021-01-12 | Metabolic Technologies, Inc. | Composition of HMB and ATP and methods of use |
| US12472200B2 (en) | 2019-05-15 | 2025-11-18 | Axcess Global Sciences, Llc | Autobiotic compositions and method for promoting healthy gut microbiome |
| US11950616B2 (en) | 2019-06-21 | 2024-04-09 | Axcess Global Sciences, Llc | Non-vasoconstricting energy-promoting compositions containing ketone bodies |
| US12167993B2 (en) | 2019-06-21 | 2024-12-17 | Axcess Global Sciences, Llc | Non-vasoconstricting energy-promoting compositions containing ketone bodies |
| US11969430B1 (en) | 2023-03-10 | 2024-04-30 | Axcess Global Sciences, Llc | Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance |
| US12186297B2 (en) * | 2020-08-26 | 2025-01-07 | Axcess Global Sciences, Llc | Compositions and methods for increasing lean-to-fat mass ratio |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4857552A (en) * | 1988-06-08 | 1989-08-15 | E. I. Du Pont De Nemours And Co. | Stable pharmaceutical composition |
| US5087472A (en) * | 1990-01-30 | 1992-02-11 | Iowa State University Research Foundation, Inc. | Feed compositions for domestics animals containing hydroxymethylbutyrate |
| US5028440A (en) * | 1990-01-30 | 1991-07-02 | Iowa State University Research Foundation, Inc. | Method of raising meat producing animals to increase lean tissue development |
| US4992470A (en) * | 1990-02-08 | 1991-02-12 | Iowa State University Research Foundation, Inc. | Method of enhancing immune response of mammals |
| US5348979A (en) * | 1992-12-23 | 1994-09-20 | Iowa State University Research Foundation Inc. | Method of promoting nitrogen retention in humans |
| US6103764A (en) * | 1997-11-07 | 2000-08-15 | Iowa State University Research Foundation, Inc. | Method for increasing the aerobic capacity of muscle |
| US6031000A (en) * | 1998-06-23 | 2000-02-29 | Iowa State University Research Foundation, Inc. | Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use |
| US20010008641A1 (en) * | 1998-11-25 | 2001-07-19 | R. Douglas Krotzer | Nutritionally active composition for bodybuilding |
| JP4744081B2 (ja) * | 2001-08-31 | 2011-08-10 | ラトガーズ， ザ ステイト ユニバーシティ オブ ニュー ジャージー | 植物抽出物を用いて障害を処置するための方法 |
| DE10215007A1 (de) * | 2002-04-05 | 2003-10-16 | Degussa Bioactives Deutschland | Verwendung von Kreatinpyruvat zur Steigerung der Ausdauer bei hochintensiven körperlichen Intervallbelastungen |
| US20040220266A1 (en) * | 2002-09-09 | 2004-11-04 | Wiley David B. | Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives |
| EP1750527A1 (en) * | 2004-03-11 | 2007-02-14 | Wiley Organics, Inc. | Compositions and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives |
| US20050215640A1 (en) * | 2004-03-26 | 2005-09-29 | Baxter Jeffrey H | HMB compositions and uses thereof |
| US20080317886A1 (en) * | 2005-11-03 | 2008-12-25 | Sparkman Dennis R | Compositions for Preventing and Reducing Delayed Onset Muscle Soreness |
| ES2689700T3 (es) * | 2008-12-09 | 2018-11-15 | Metabolic Technologies, Inc. | Intervención nutricional para mejorar la función y resistencia muscular |
| JP2009155336A (ja) * | 2009-03-31 | 2009-07-16 | Tsujido Chemical Corp | 治療剤 |
-
2010
- 2010-12-20 ES ES10838355.5T patent/ES2608483T3/es active Active
- 2010-12-20 US US12/973,803 patent/US20120053240A1/en not_active Abandoned
- 2010-12-20 HU HUE10838355A patent/HUE032486T2/en unknown
- 2010-12-20 JP JP2012544948A patent/JP6077857B2/ja active Active
- 2010-12-20 CN CN201080064031.3A patent/CN102762097B/zh active Active
- 2010-12-20 DK DK10838355.5T patent/DK2512236T3/en active
- 2010-12-20 PL PL10838355T patent/PL2512236T3/pl unknown
- 2010-12-20 WO PCT/US2010/061367 patent/WO2011075741A1/en not_active Ceased
- 2010-12-20 PT PT108383555T patent/PT2512236T/pt unknown
- 2010-12-20 CA CA2784836A patent/CA2784836C/en active Active
- 2010-12-20 EP EP10838355.5A patent/EP2512236B1/en active Active
-
2015
- 2015-09-25 JP JP2015188107A patent/JP2016026181A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013515009A5 (enExample) | ||
| JP2011225596A5 (enExample) | ||
| ME02662B (me) | Niskofrekventna terapija glatiramer acetatom | |
| EP3509596B1 (en) | Norketotifen for treatment of hypercytokinemia and viral infections | |
| JP2010522698A5 (enExample) | ||
| US20250057792A1 (en) | Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (hmb) for decreasing fat mass | |
| NZ601195A (en) | Topical transdermal dexmedetomidine compositions and methods of use thereof | |
| JP2011528333A5 (enExample) | ||
| JP2016508123A5 (enExample) | ||
| MX352647B (es) | Metodo para temporizar una colonoscopia en donde se administra una composicion de picosulfato. | |
| RU2009142937A (ru) | Тапентадол для лечения в связи с остеоартрозом | |
| JP2013526611A5 (enExample) | ||
| JP2019529533A (ja) | 皮膚ケアおよび／または創傷治癒促進におけるポリ抽出物およびその有効成分の使用 | |
| RU2019111096A (ru) | Лекарственные формы леводопы для быстрого купирования болезни паркинсона | |
| RU2014103800A (ru) | Олигосахаридная композиция для предотвращения или снижения риска метаболического синдрома | |
| JP2017508737A5 (enExample) | ||
| CN104666327B (zh) | 低聚甘露糖醛酸及其衍生物在制备抗疲劳和抗肌萎缩的药物和保健品中的应用 | |
| CN103263427A (zh) | 新橙皮苷在制备防治高脂血症药物中的应用 | |
| CN110585181A (zh) | 丁内酯代谢酮i在抗炎中的应用 | |
| JP2017508455A5 (enExample) | ||
| CA2489705A1 (en) | Use of amide derivative of ge 2270 factor a3 for the treatment of acne | |
| US20070066567A1 (en) | Use of phospholipid arachidonic acids for increasing muscle mass in humans | |
| Matsumoto et al. | Clinical application of ghrelin for chronic respiratory failure | |
| CN113197887B (zh) | 5-羟甲基糠醛在制备抗病毒药物中的应用 | |
| RU2013148539A (ru) | Алиспоривир для лечения инфекции вируса гепатита с |